This post is from a suggested group
Tuberculosis Vaccine Treatment: Understanding Immunization, Prevention Strategies, and Advancements in TB Control
Tuberculosis remains a global public health challenge, and vaccine-based treatment continues to be one of the most effective tools for prevention. The Bacillus Calmette–Guérin (BCG) vaccine has been used for decades and offers significant protection against severe forms of tuberculosis in children, including miliary TB and tuberculous meningitis.
In adults, its protective effect varies, prompting ongoing research to develop improved vaccine candidates. Scientists are exploring recombinant vaccines, viral vector–based vaccines, and subunit vaccines designed to stimulate stronger immune responses. These next-generation vaccines aim to provide durable protection against pulmonary TB, which is the most infectious form of the disease.
Vaccine treatment for TB is often paired with early detection, adherence to medication, and public health initiatives. The integration of immunization strategies with molecular diagnostics and preventive therapies is transforming TB management, especially in high-burden regions.